Schroder Investment Management Group
ATRS

Schroder Investment Management Group’s Antares Pharma, Inc. ATRS Stock Holding History

Schroder Investment Management Group’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-90,591
Closed -$330K – 1545
2021
Q3 		$330K Buy
90,591
+35,289
+64% +$143K ﹤0.01% 1268
2021
Q2 		$241K Hold
55,302
– – ﹤0.01% 1311
2021
Q1 		$227K Sell
55,302
-60,856
-52% -$264K ﹤0.01% 1311
2020
Q4 		$464K Buy
116,158
+96,040
+477% +$311K ﹤0.01% 1212
2020
Q3 		$58K Buy
+20,118
New +$55.7K ﹤0.01% 1260

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Schroder Investment Management Group's ATRS Position: Q4 2021 in Review

Schroder Investment Management Group sold out of Antares Pharma, Inc. (ATRS) in Q4 2021, closing a stake of 90,591 shares — an estimated $330K sold.

Schroder Investment Management Group first reported a position in ATRS in Q3 2020 and held it in 5 quarters. The position peaked at $464K in Q4 2020. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

  • Schroder Investment Management Group reported no remaining Antares Pharma, Inc. position as of Q4 2021 after selling out during the quarter.
  • Schroder Investment Management Group sold 90,591 Antares Pharma, Inc. shares in Q4 2021, an estimated $330K.
  • Schroder Investment Management Group first reported a position in Antares Pharma, Inc. in Q3 2020 and held it in 5 quarters.
  • Schroder Investment Management Group's Antares Pharma, Inc. position peaked at $464K in Q4 2020.
  • 162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on Schroder Investment Management Group's 13F filing for Q4 2021, filed 14 Feb 2022.